Skip to main content
. 2015 Sep 25;10(9):e0137474. doi: 10.1371/journal.pone.0137474

Fig 6. Soluble FcR levels in early RA are regulated by anti-rheumatic treatment.

Fig 6

The plasma levels of sCD89 (A), sCD64 (B) and sCD16a (C) in healthy controls (HC)(n = 20), in patients with active polyarticular psoriatic arthritis (PsA) (n = 22), and in early RA patients (n = 19) before and after treatment with anti-rheumatics. (FV = first visit, FU = follow-up).